Skip to main content

Table 1 Clinical features of the dialysis patients who had positive COVID-PCR

From: Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody

 

Total %

(n = 152)

Alive %

(n = 138)

Died %

(n = 14)

P-value*

Demographics

Age, y

52.4 (12.1)

51.2 (11.3)

64.1 (3.5)

0.002

Male Sex, %

81 (123)

81 (112)

79 (11)

ns

Co-morbidities

Diabetes, % (n)

51 (78)

54 (75)

21 (3)

0.024

Cardiovascular disease, % (n)

70 (106)

72 (100)

43 (6)

0.032

Smoker, % (n)

43 (65)

41 (57)

57 (8)

ns

Presenting symptoms

Fever, % (n)

49 (74)

44 (61)

93 (13)

< 0.001

Cough, % (n)

47 (72)

43 (60)

86 (12)

0.004

Dyspnoea, % (n)

16 (24)

12 (16)

57 (8)

< 0.001

Myalgia, % (n)

13 (19)

12 (17)

14 (2)

ns

GI symptoms, % (n)

6 (9)

4 (6)

21 (3)

0.038

Disease severity

Mild, % (n)

68 (104)

75 (103)

7 (1)

ns

Moderate, % (n)

21 (32)

20 (28)

29 (4)

ns

Severe, % (n)

11 (16)

44 (7)

64 (9)

< 0.001

Radiological findings

Abnormal chest x-ray, % (n)

45 (68)

40 (55)

93 (13)

< 0.001

Abnormal chest CT, % (n)

53 (80)

49 (67)

93 (13)

0.001

  1. *P-value determined using two-sample Wilcoxon rank-sum (Mann-Whitney) test for continuous variables and Fisher's exact test for categorical variables